| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.015 | 0.8 |